Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Longpan Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 10
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Therapeutics

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kangpu Bio-Pharma

Biopharma
Clinical Trials
Health Care
$15M30 Aug 2023 Shanghai, China

Cascade

Biopharma
Biotechnology
Health Care
Medical
$21M14 Aug 2023 Shanghai, China

Enchannel

Biotechnology
Medical
Therapeutics
$30M01 Aug 2023 Huangpu, Shanghai, China

BDGENE THERAPEUTICS

Biotechnology
Cloud Computing
Health Care
Internet of Things
Medical
Pharmaceutical
SEO
$30M27 Jun 2023 Minhang District, China

D2M Biotherapeutics

Biotechnology
Health Care
Therapeutics
03 Apr 2023 -

D2M Biotherapeutics

Biotechnology
Health Care
Therapeutics
$20M26 Dec 2022 -

Puqi Pharmaceutical

Emergency Medicine
Health Care
Medical
12 Dec 2022 Fengtai, Beijing, China

SynRx Therapeutics

Biopharma
Biotechnology
Medical
16 Nov 2022 Yuhang, Zhejiang, China

DeepKinase

Biotechnology
Medical
01 Jan 2022 Haidian, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Longpan Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 15M
Peak activity year 2023
Lead investments 3
Follow on index 0.09
Group Appearance index 0.91

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Kangpu Bio-Pharma

Biopharma
Clinical Trials
Health Care
$15M30 Aug 2023 Shanghai, China

Cascade

Biopharma
Biotechnology
Health Care
Medical
$21M14 Aug 2023 Shanghai, China

Enchannel

Biotechnology
Medical
Therapeutics
$30M01 Aug 2023 Huangpu, Shanghai, China

BDGENE THERAPEUTICS

Biotechnology
Cloud Computing
Health Care
Internet of Things
Medical
Pharmaceutical
SEO
$30M27 Jun 2023 Minhang District, China

D2M Biotherapeutics

Biotechnology
Health Care
Therapeutics
03 Apr 2023 -

D2M Biotherapeutics

Biotechnology
Health Care
Therapeutics
$20M26 Dec 2022 -

Puqi Pharmaceutical

Emergency Medicine
Health Care
Medical
12 Dec 2022 Fengtai, Beijing, China

SynRx Therapeutics

Biopharma
Biotechnology
Medical
16 Nov 2022 Yuhang, Zhejiang, China

DeepKinase

Biotechnology
Medical
01 Jan 2022 Haidian, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: